Valencia Thomas, MD
MOHS-Micrographic Surgery · Houston, TXNPI 1861424129
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,145 of the $5,443 with a category attached, or 94.5%. Regeneron Healthcare Solutions, Inc. accounts for 70.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $4,110 and has fallen 95.3% since, to $194 in 2025.
Across 10 payments — averaging $544.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$4K
- Merck$1K
- E.r. Squibb & Sons, L.L.C.$125
- Amgen$48
What the payments were for
- Consulting fees$5,14595%
- Food & beverage$2985%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $3,833 |
| Merck | 4 | $1,437 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Amgen | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,443 in reported general payments places this provider in the 75th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 383 | $4,155 |
| Cephalexin | 420 | $1,802 |
| Doxycycline Hyclate | 122 | $1,286 |
| Celecoxib | 120 | $1,251 |
| Fluorouracil | 20 | $1,073 |
| Gentamicin Sulfate | 18 | $896 |
| Clobetasol Propionate | 36 | $777 |
| Imiquimod | 22 | $690 |
| Ketoconazole | 31 | $619 |
| ErythromycinErythromycin Base | 32 | $281 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 74 | $271 |
| Triamcinolone Acetonide | 12 | $143 |
| ValacyclovirValacyclovir Hcl | 12 | $117 |
| Gabapentin | 24 | $67 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Houston
- Paul FriedmanHouston$131K
- Janet LiHouston$9K
- Joseph SedrakHouston$8K
- Sonal ParikhHouston$3K
- Leon ChenHouston$1K
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.